报价延迟最少15分钟:2026/06/30 17:34 EDT
盘后时段
|
||||
|
4.924269 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.93
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.24/5.91
|
|
企业价值
22.43B
|
| 资产负债 |
|
每股账面净值
-5.51
|
| 现金流量 |
|
现金流量率
0.78
|
| 损益表 |
|
收益
10.27B
|
|
每股收益
27.49
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reportsrevenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment. |
